Results 21 to 30 of about 27,659 (257)

Emergence of genetically linked vaccine-originated poliovirus type 2 in the absence of oral polio vaccine, Jerusalem, April to July 2022. [PDF]

Euro Surveill, 2022
Zuckerman NS, Bar-Or I, Sofer D, Bucris E, Morad H, Shulman LM, Levi N, Weiss L, Aguvaev I, Cohen Z, Kestin K, Vasserman R, Elul M, Fratty IS, Geva M, Wax M, Erster O, Yishai R, Hecht-Sagie L, Alroy-Preis S, Mendelson E, Weil M.   +21 more
europepmc   +3 more sources

Oral Polio Vaccine to Mitigate the Risk of Illness and Mortality During the Coronavirus Disease 2019 Pandemic: A Cluster-Randomized Trial in Guinea-Bissau. [PDF]

Open Forum Infect Dis, 2022
Fisker AB, Martins JSD, Nanque LM, Jensen AM, Ca EJC, Nielsen S, Martins CL, Rodrigues A.   +7 more
europepmc   +3 more sources

Monitoring the Risk of Type-2 Circulating Vaccine-Derived Poliovirus Emergence during Roll-Out of Type-2 Novel Oral Polio Vaccine [PDF]

Vaccines (Basel)
Peak CM, Lyons H, Voorman A, Gray EJ, Cooper LV, Blake IM, Hawes K, Bandyopadhyay AS.   +7 more
europepmc   +6 more sources

Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in Panama. [PDF]

Viruses, 2021
Rojas-Bonilla M, Coulliette-Salmond A, Belgasmi H, Wong K, Sayyad L, Vega E, Grimoldi F, Oberste MS, Rüttimann R.   +8 more
europepmc   +3 more sources

Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region. [PDF]

J Infect Dis, 2017
The Polio Eradication and Endgame Strategic plan outlines the phased removal of oral polio vaccines (OPVs), starting with type 2 poliovirus-containing vaccine and introduction of inactivated polio vaccine in routine immunization to mitigate against risk of vaccine-associated paralytic polio and circulating vaccine-derived poliovirus.
Tevi-Benissan C, Okeibunor J, du Châtellier GM, Assefa A, Biey JN, Cheikh D, Eshetu M, Anya BP, Dao H, Nasir Y, Akanmori BD, Mihigo R.   +11 more
europepmc   +4 more sources

Time for a Worldwide Shift from Oral Polio Vaccine to Inactivated Polio Vaccine [PDF]

Clinical Infectious Diseases, 2009
Aamir Shahzad
openaire   +4 more sources

Implementing a robust adverse event of special interest surveillance for novel oral polio vaccine type 2 rollout, Nigeria, March-July 2021. [PDF]

Pan Afr Med J, 2023
Abbott SL, Etapelong SG, Gidado S, Mawashi KY, Edukugho AA, Hamisu AW, Shehu A, Adedire E, Hassan IA, Waziri NE, Bolu O, Adamu US.   +11 more
europepmc   +2 more sources

Oral Polio Vaccine Campaigns May Reduce the Risk of Death from Respiratory Infections. [PDF]

Vaccines (Basel), 2021
Nielsen S, Sujan HM, Benn CS, Aaby P, Hanifi SMA.   +4 more
europepmc   +3 more sources

Poliomyelitis amidst the COVID-19 pandemic in Africa: Efforts, challenges and recommendations

Clinical Epidemiology and Global Health, 2022
Poliomyelitis is the leading infectious cause of acute flaccid paralysis among children under five years of age, caused by the Wild Poliovirus, with no medical cure other than prevention through vaccination.
Olivier Uwishema, Emmanuel Ebuka Elebesunu, Oumnia Bouaddi, Arushi Kapoor, Samaa Akhtar, Fortune Benjamin Effiong, Adhiraj Chaudhary, Helen Onyeaka   +7 more
doaj   +1 more source

War on Disease

Historia.scribere, 2023
This paper investigates how widespread acceptance of the polio vaccination was generated in the United States. It shows that FDR transformed the struggle against polio into a national endeavor and that the fear of polio contributed to the widespread ...
Jonas Zimmermann
doaj   +1 more source